Angioblast-mesenchyme induction of early kidney development is mediated by Wt1 and Vegfa by Gao, X. B. et al.
5437
Introduction
Epithelial-mesenchymal inductive interactions have long been
the hallmark of organ development, especially of those organs
that develop specialized epithelial and/or undergo branching
morphogenesis, such as the kidney, lung, liver, pancreas and
other secretory glands. In the case of the kidney, interaction
of the epithelial ureteric bud with the metanephric
mesenchyme, a histologically distinct patch of cells in the
urogenital ridge, leads to condensation of the mesenchyme
around the branching ureteric bud, and the subsequent
induction of a mesenchymal-to-epithelial transformation of
the condensed mesenchyme into tubular elements called
nephrons (Saxen, 1987). This process is reiterated by
continual branching of the ureteric bud and expansion of the
mesenchyme until, in the human kidney, approximately one
million nephrons have been induced. Many genes have
been identified with a function required for these initial
interactions. For example, the transcription factors Wt1, Pax2,
Six1 and Eya1 are expressed in the metanephric mesenchyme,
and in the absence of any one of these factors, the ureteric
bud either fails to emerge from the Wolffian duct or fails to
invade the metanephric mesenchyme, thus blocking kidney
development at its earliest stages (Kreidberg et al., 1993;
Torres et al., 1995; Xu et al., 1999; Xu et al., 2003).
Many recent studies have significantly advanced our
understanding of the molecular basis of ureteric bud-
mesenchymal interactions that initiate kidney development.
For example, Pax2 has been shown to regulate the expression
of glial cell line derived neurotrophic factor (Gdnf) (Brophy et
al., 2001), a member of the neurotrophin family expressed by
the metanephric and condensed mesenchyme, which binds the
c-Ret receptor expressed at the tip of the ureteric bud to
stimulate growth and branching of the bud (Durbec et al., 1996;
Sanicola et al., 1997; Trupp et al., 1996). In Gdnf-deficient
embryos, there is no outgrowth of the ureteric bud (Moore et
al., 1996; Pichel et al., 1996; Sanchez et al., 1996). Compared
with that of Pax2, our understanding of how the Wt1 gene
regulates the interactions that initiate kidney development is
less well understood. Wt1 encodes a zinc finger transcription
factor; this gene was first identified as a tumor suppressor gene
for Wilms’ tumor, a neoplasm of the kidney that occurs in
young children (Call et al., 1990; Gessler et al., 1990; Glaser
et al., 1989). Wt1 is expressed in the metanephric mesenchyme
and increases in expression as the mesenchyme condenses
around the ureteric bud, finally being restricted to the podocyte
Most studies on kidney development have considered the
interaction of the metanephric mesenchyme and the
ureteric bud to be the major inductive event that maintains
tubular differentiation and branching morphogenesis. The
mesenchyme produces Gdnf, which stimulates branching,
and the ureteric bud stimulates continued growth of the
mesenchyme and differentiation of nephrons from the
induced mesenchyme. Null mutation of the Wt1 gene
eliminates outgrowth of the ureteric bud, but Gdnf has
been identified as a target of Pax2, but not of Wt1. Using a
novel system for microinjecting and electroporating
plasmid expression constructs into murine organ cultures,
it has been demonstrated that Vegfa expression in the
mesenchyme is regulated by Wt1. Previous studies had
identified a population of Flk1-expressing cells in the
periphery of the induced mesenchyme, and adjacent to the
stalk of the ureteric bud, and that Vegfa was able to
stimulate growth of kidneys in organ culture. Here it is
demonstrated that signaling through Flk1 is required to
maintain expression of Pax2 in the mesenchyme of the early
kidney, and for Pax2 to stimulate expression of Gdnf.
However, once Gdnf stimulates branching of the ureteric
bud, the Flk1-dependent angioblast signal is no longer
required to maintain branching morphogenesis and
induction of nephrons. Thus, this work demonstrates the
presence of a second set of inductive events, involving the
mesenchymal and angioblast populations, whereby Wt1-
stimulated expression of Vegfa elicits an as-yet-unidentified
signal from the angioblasts, which is required to stimulate
the expression of Pax2 and Gdnf, which in turn elicits an
inductive signal from the ureteric bud.
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population of the glomerulus, where it continues to be
expressed in the mature kidney. Many genes have been
identified as potential targets for Wt1 (Scharnhorst et al., 2001),
but it has been difficult to reconcile these findings with the
renal agenesis phenotype of Wt1-deficient embryos (Kreidberg
et al., 1993). For example, amphiregulin has been identified as
a target for Wt1 (Lee et al., 1999) and stimulates branching
morphogenesis in kidney organ cultures, but amphiregulin
mutant mice demonstrate normal kidney development
(Luetteke et al., 1999). Whether this can be accounted for by
redundancy among EGF family members is not known.
Recently, we reported the phenotype of transgenic mice in
which a truncated form of Wt1, expected to act in a dominant-
negative fashion, was specifically expressed in glomerular
podocytes, which are Wt1-expressing cells that form part of the
filtration unit of the kidney (Natoli et al., 2002a). Surprisingly,
instead of yielding defects in podocyte differentiation,
expression of the mutant form of Wt1 resulted in abnormal
development of the glomerular capillaries that form in intimate
contact with the podocytes. This observation has led us to
hypothesize that one function of Wt1 is to regulate the
expression of growth factors that are involved in vascular
development. A role for growth factors that stimulate vascular
development in kidney development was first suggested by
Tufro, who demonstrated that vascular endothelial growth
factor A (Vegfa), or hypoxic culture conditions, could stimulate
proliferation and nephrogenesis in metanephric kidney organ
cultures (Tufro, 2000; Tufro et al., 1999; Tufro-McReddie et
al., 1997). Here we present results demonstrating that Wt1 does
indeed regulate the expression of Vegfa. Furthermore, it is
shown that Vegfa produced by the mesenchyme stimulates
branching morphogenesis and nephrogenesis in the early
kidney through reciprocal inductive events that involve a
population of Flk1 (Vegfr2; Kdr – Mouse Genome
Informatics)-expressing angioblasts. Thus, similarly to recent
studies identifying a role for angiogenic cells in hepatogenesis
and pancreatic development (Lammert et al., 2001; Matsumoto
et al., 2001), this work identifies an interaction between
angioblasts and the condensed mesenchyme as an additional
crucial interaction involved in early kidney development, in
addition to the classically recognized inductive interaction
between the mesenchyme and the ureteric bud (Grobstein,
1953).
Materials and methods
Antibodies and other materials
Recombinant mouse Vegfa (#493-MV), recombinant rat Gdnf (#512-
GF) and goat polyclonal anti-Vegfa antibody (#AF-493-NA) were
purchased from R&D Systems (Minneapolis, MN); rat polyclonal
anti-Flk1 antibody (#550549) for immunostaining was purchased
from BD Biosciences (San Diego, CA); rat polyclonal anti-Flk1
antibody (clone DC101) was obtained from ImClone Inc. (New York,
NY); mouse polyclonal anti-pan-cytokeratin antibody was purchased
from Sigma (St Louis, MO); rabbit polyclonal anti-Pax2 antibody
(#71-600) was purchased from Zymed (South San Francisco, CA) or
obtained from Dr Greg Dressler, (University of Michigan); rabbit
polyclonal anti-Pecam antibody (H-300)), goat polyclonal anti-Pecam
antibody (M-20) and rat-IgG were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA); rabbit polyclonal anti-Brush Border
antibody (Miettinen and Linder, 1976) was obtained from Hannu
Sariola (University of Helsinki). All secondary antibodies were
purchased from Jackson ImmunoResearch (West Grove, PA).
Tyrphostin SU1498 (#T-2710) was purchased from Calbiochem (La
Jolla, CA); DMSO was purchased from Fisher Scientific (Pittsburgh,
PA). A plasmid encoding a truncated version of Flk1 (Tsou et al.,
2002) was obtained from Dr F. Frank Isik, (University of Washington,
Seattle). Lotus lectin (FL-1321) was purchased from Vector
laboratories, Inc. (Burlingame, CA).
Microinjection and electroporation
The electroporation system modified from that previously used to
microinject chick neural tubes (Itasaki et al., 1999; Nakamura et al.,
2000) is depicted in Fig. 1A. Metanephric kidney organ cultures were
placed in a dish under a drop of buffer, and plasmid vectors were
injected into the culture using 15-20 m diameter glass needles
prepared using a Sutter Instrument micropipette puller model P-87
(Sutter Instruments, Novato, CA). Settings on the pipette puller were:
Heat 400; Pull 150; Velocity 100; Time 100. The glass tubes for
making needles were obtained from Sutter, (#BF100-50-10), outer
diameter 1.0 mm, inner diameter 0.5 mm, 10 cm length. Needles were
connected by thin tubing to a FemtoJet microinjection device
(Eppendorf, Hamburg, Germany) using the following settings:
injection Pressure 6.00 psi; compensation pressure 1.00 psi; injection
time 0.4 seconds, two injections per injection site. A square wave
electroporator (BTX ECM830, Genetronics Inc., San Diego, CA) was
used to pulse the culture immediately after the injection, using
rectangular electrodes (gold plated, Model 516, Genetronics Inc.)
placed in parallel on either side of the organ culture before the
injection. The parameters used here were voltage: 36 V; number of
pulse: 5; pulse length: 50 ms; internal time: 100 ms. After growing
for 6-48 hours, cultures were analyzed to examine gene expression,
culture growth and differentiation.
In-vitro kidney cultures and immunocytochemistry
Embryonic day (E) 11.5 metanephric rudiments were isolated from
embryos of FVB mice, placed on nitrocellulose filters (0.1 m pore
size, Nuclepore Track-Etch Membrane, Whatman 0930059),
suspended over DMEM/10% fetal calf serum (FCS) and cultured at
the air/medium interface for 24, 36, 48 or 72 hours at 37°C with 5%
CO2. Blocking antibodies or pharmacological agents were added to
the growth medium as mentioned for each experiment. Kidney
cultures were fixed in 4% paraformaldehyde (PFA) for in situ
hybridization with RNA probes, or fixed in methanol and stained
with antibodies. Branch tips were quantified by manual counting
after anti-cytokeratin staining, nephron proximal tubule units were
identified by staining with Lotus lectin or Brush Border antibody.
Results were statistically analyzed by Student’s t-test. Antibody
staining: kidney cultures were fixed in ice-cold methanol for 10
minutes, washed in PBS containing 1% bovine serum albumin
(BSA) at room temperature and incubated overnight in primary
antibodies at 4°C. The samples were then washed three times for 2
hours each in PBS at room temperature and incubated overnight in
secondary antibodies at 4°C. Finally, after washing three times for
2 hours each in PBS at room temperature, organ cultures were
analyzed using an inverted fluorescence microscope (Nikon Eclipse
TE 300), and imaged using a Spot 1.4.0 digital camera (Diagnostic
Instruments, Sterling Heights, MI). Images were processed on
Macintosh computers using Photoshop 6.0 (Adobe Systems, Inc.,
San Jose, CA). Fluorescent alkaline phosphatase (AP) detection
used for Flk1 staining was essentially as published (Natoli et al.,
2004).
In situ hybridization
Riboprobes were obtained or generated from the coding region of
mouse Gdnf (Srinivas et al., 1999) (obtained from F. Costantini,
Columbia University), Wt1 (Pelletier et al., 1991), Vegf164 (bases 75-
669 in the murine cDNA, amplified by PCR), Pax2 [(Dressler et al.,
1990), obtained from P. Grus], Nanog [generated in our laboratory
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cDNA 558-1140 (Chambers et al., 2003; Mitsui et al., 2003)], Osr1
[(So and Danielian, 1999), obtained from P. Danielian, Chester Beatty
Laboratories, London] and Wnt4 [(Stark et al., 1994), obtained from
S. Vainio, University of Oulu, Finland], and subcloned in pCDNA3
or pCRII-TOPO (Invitrogen). Sense and antisense probes were
synthesized and labeled with digoxigenin-UTP (Roche). The protocol
used for whole-mount in situ hybridization was as published
(Wilkinson and Nieto, 1993). For section in situs, material was fixed
in 4% paraformaldehyde and embedded in paraffin. Sections were cut
at 8uM and deparaffinized through xylene and a standard ethanol
series.
Real-time PCR analysis
As specified in the Results section, RNA was prepared either from
whole organ cultures or from sections co-injected with a GFP
expression plasmid, in which case GFP-expressing sections were
micro-dissected apart from the rest of the organ culture. Total RNA
was isolated from kidney organ cultures, digested with DNase 1
(Qiagen) and reverse-transcribed with SuperScript First-Strand
Synthesis System kit (Invitrogen) to get cDNA template. For Smart
Cycler Real-Time PCR reaction, a mastermix of the following
reaction components was prepared to the indicated end-concentration:
Water (RNase free), forward primer (0.3 mol/l), reverse primer (0.3
mol/l), TaqMan probe (0.2 mol/l, Cepheid), Q solution (1,
Qiagen), dNTPs (0.2 mmol/l, Biolabs), PCR buffer (1, containing
15 mmol/l MgCl2, Qiagen), Taq DNA polymerase (0.1 unit/l,
Biolabs), cDNA template (5 ng/l). Smart Cycler reaction mastermix
was filled in the Smart Cycler reaction tubes [Cepheid (Sunnyvale,
CA)], which were closed, centrifuged and placed into the Smart
Cycler processing block (Cepheid). The following protocols were
used: for Gapdh and Vegfa, 94°C for 120 seconds; 94°C for 60
seconds, 58°C for 30 seconds, 72°C for 30 seconds, 40 cycles; cool
to 4°C. For Pax2, 94°C for 120 seconds; 94°C for 30 seconds, 58°C
for 30 seconds, 72°C for 45 seconds, 40 cycles; cool to 4°C. For Gdnf,
94°C for 120 seconds; 94°C for 30 seconds, 60°C for 45 seconds,
72°C for 45 seconds, 40 cycles; cool to 4°C. Primers used were: gapdh
(Forward: TCC ACC CAT GGC AAA TTC A; Reverse: TCG CTC
CTG GAA GAT GGT), Vegfa (Forward: AGC AAC ATC ACC ATG
CAG AT; Reverse: TCA CAG TGA TTT TCT GGC TTT G), Pax2
(Forward: TGG CTG TGT CAG CAA AAT CCT; Reverse:
ATTCGGCAATCTTGTCCACCA), and Gdnf (Forward: TTC GCG
CTG ACC AGT GA; Reverse: CTC TCT TCG AGG AAG CGC T).
Standard curves of Gapdh, Vegfa, Pax2 and Gdnf were generated using
cDNA dilutions from 10–3 g/l to 10–7 g/l (data not shown); each
dilution was run in triplicate, and Ct values all varied by less than ±0.4
unit cycles. Vegfa, Pax2 and Gdnf Ct values were normalized using
Gapdh Ct values using the following equation: Vegfa corrected Ct
(sample 1) = Vegfa obtained Ct (sample 1)  Gapdh Ct (sample 2) /
Gapdh Ct (sample 1). Ct values were converted to relative mRNA
values using the Vegfa, Pax2 or Gdnf standard curves.
Results
Organ culture microinjection and electroporation
Using Wt1–/– embryos to evaluate potential downstream targets
of the Wt1 gene has been problematic, as the metanephric
mesenchyme in these mutant embryos begins to undergo
apoptosis almost immediately upon its formation as a
histologically distinct structure (Kreidberg et al., 1993).
Therefore, whether a gene is expressed or not may be due to
the apoptotic program rather than whether it is a valid
target of Wt1. To circumvent this issue, we adapted a
microinjection/electroporation system previously used in chick
neural tubes (Itasaki et al., 1999; Nakamura et al., 2000) to the
study of Wt1 function in murine organ culture (Fig. 1A)
because it allows higher-throughput experimentation than the
derivation of a novel transgenic mouse line for each individual
transgene. Additionally, this approach allows gene expression
in locations for which no appropriate promoter is available,
such as the metanephric mesenchyme. Thus, rather than
studying loss-of-function phenotypes in Wt1 mutant embryos,
this system allows the observation of gain-of-function
phenotypes in organ cultures in which Wt1 or other genes have
been overexpressed. This system also allows the evaluation of
Wt1 target genes in non-immortalized cells, avoiding the
Fig. 1. Microinjection and electroporation system for kidney organ
cultures. (A) A diagram of the microinjection and electroporation
system. (a) A three-dimensional depiction, showing a pair of
electrodes on the left, and the injection needle on the right. (b) A
view from above the organ culture; showing the injection needle
placed in the condensed mesenchyme. The dotted line shows the
boundary of the whole organ culture. Injections can also be placed
outside the condensed mesenchyme, within the looser mesenchyme
of the organ culture. (c) Whole-mount double exposure of brightfield
image of organ culture and GFP fluorescence 24 hours after
injection. (B-E) Gdnf injection/electroporation. (B,D,E) A Gdnf
expression vector was injected outside the condensed mesenchyme,
adjacent to the Wolffian duct, as shown by the arrow in B. (C) An
empty vector was injected as a negative control. (B,C) Cytokeratin
stains done 36 hours post-injection to demonstrate the presence of
ectopic ureteric buds emerging from the Wolffian duct. Several are
present in B, none in C, next to the yellow arrows. (D,E) In situ
hybridization for Gdnf, using antisense (D) and sense (E) probes. The
endogenous Gdnf mRNA signal is too weak to be detected under
these hybridization conditions. CM, condensed mesenchyme; UB,
ureteric bud.
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possibility that Wt1 function is modified when co-expressed
with immortalizing proteins. As described in the Materials and
methods section, an organ culture was placed between two
electrodes, DNA plasmid expression constructs were
microinjected into the mesenchymal component of the organ
rudiment, and the culture was electroporated immediately after
the injection. After an additional 6-48 hours in culture, these
cultures were analyzed to examine gene expression, culture
growth and differentiation.
As a first test of this system, a green fluorescent protein
(GFP) expression construct (pCS2-EGFP) was microinjected
into the E11 kidney organ cultures (Fig. 1A, part c). GFP was
highly expressed in multiple cell layers at the site of injection
(see Fig. S1 in the supplementary material; additionally, Fig.
S2 shows a slight decrease in branching number as a
consequence of electroporation, but the pattern of Pax2 and
Wt1 expression is preserved). To further examine the ability
of this system to manipulate biologically relevant aspects of
kidney development, a vector encoding Gdnf, the major
growth factor responsible for stimulating growth of the
ureteric bud (Sainio et al., 1997; Sanicola et al., 1997), was
introduced into the organ culture by microinjection/
electroporation. Localized expression of Gdnf adjacent to the
Wolffian duct led to outgrowth of ectopic ureteric buds from
the Wolffian duct, adjacent to the site of injection (Fig. 1B,
compare with Fig. 1C). This was observed in 100% of
injections (the success rate for all experiments is presented
in Table 1). Injection of an empty vector that did not
contain the Gdnf cDNA never resulted in ectopic bud
outgrowth from the Wolffian duct (Fig. 1C). In situ
hybridization with a Gdnf RNA probe showed strong
expression of Gdnf at the site of injection (Fig. 1D, compare
with sense probe, Fig. 1E).
Overexpression of Wt1 stimulates branching of the
ureteric bud
Having established the efficacy of the microinjection/
electroporation system for use in metanephric kidney organ
culture, Wt1 was overexpressed in an attempt to identify
possible Wt1 target genes. In situ hybridization with a Wt1
antisense probe showed increased signal at the site of the Wt1
plasmid injection (Fig. 2A, part a, compare with sense probe
Fig. 2A, part c), whereas no increased signal was found after
injection of a control GFP expression vector (Fig. 2A, part b).
Overexpression of Wt1 in the condensed mesenchyme (after
injection at multiple sites) led to increased branching of the
ureteric bud (Fig. 2A, parts d,f, compare with Fig. 2A, part e).
The condensed mesenchyme refers to the portion of the
metanephric mesenchyme that condenses around the ureteric
bud upon its invasion of the metanephric mesenchyme, and in
which expression of genes such as Pax2 and Wt1 increases as
a consequence of induction by the bud (Schedl and Hastie,
2000). These results indicate that this system might be suitable
for the evaluation of potential Wt1 target genes involved in
early kidney development.
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Fig. 2. Injection of the Wt1 expression vector. (A) Effect on
branching morphogenesis. (a,c,d) Injection of Wt1 cDNA. (b,e)
Injection of GFP vector. In situ hybridization with Wt1 antisense
probe (a,b), or sense probe (c). The strong area of hybridization is at
the single injection site (a), and the endogenous Wt1 signal is
observed at several induced nephrons (a,b). (d,e) Cytokeratin staining
demonstrating effect of Wt1 on branching. In experiments designed
to observe an effect on branching, the vector is injected at two sites,
one on either side of the ureteric bud. The branching comparisons
shown in each figure are between organ cultures obtained from the
same embryo. (f) Overall quantitation of 12 pairs of experiments,
represented by d,e. Significant differences in branching were
detected after Wt1 injection (P<0.001). (B) Wt1 stimulation of Vegfa
expression. Injection of Wt1 (a,c) and Gfp (b) expression vectors. In
situ hybridization with Vegfa antisense (a,b) and sense (c) probes. (d)
Real-time PCR with Vegfa primers in response to microinjections. As
described in the text, a Gfp expression vector was co-injected, and
areas of Gfp expression were separated from the remainder of the
organ culture. The expression vectors used are shown at the bottom
of each column. Increased Vegfa mRNA is observed in response to
injection of a Wt1 expression vector. All Vegfa Ct values were
normalized to the Gapdh Ct value from real-time PCR for the
injected tissue.
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Table 1. Summary
Figure Injection Treatment Observation Total number Positive
Fig. 1B,C Empty vector None Ectopic ureteric bud 8 0
Fig. 1B,C Gfnf cDNA None Ectopic ureteric bud 8 8
Fig. 2A, parts d,e Gfp vector None Increased branching 12 0
Fig. 2A, parts d,e Wt1 None Increased branching 12 11
Fig. 2B, parts a,b Gfp vector None Increased Vegfa expression 12 0
Fig. 2B, parts a,b Wt1–/– None Increased Vegfa expression 20 19
Not shown* Wt1–/+ None Increased Vegfa expression 6 6
Not shown* Wt1+/– None Increased Vegfa expression 3 3
Not shown* Wt1+/+ None Increased Vegfa expression 3 3
Fig. 3B None PBS buffer Increased branching and nephrons 4 0
Fig. 3B None Vegfa protein Increased branching and nephrons 4 4
Not shown Gfp vector None Increased branching 10 0
Not shown Vegfa cDNA None Increased branching 10 10
Fig. 3C None Goat IgG Decreased branching and nephrons 4 0
Fig. 3C None Vegfa Ab Decreased branching and nephrons 4 4
Fig. 4B None Rat-IgG Decreased branching and nephrons 8 0
Fig. 4B None Flk1 Ab Decreased branching and nephrons 8 8
Not shown* Gfp vector None Decreased branching 5 0
Not shown* dnFlk1 cDNA† None Decreased branching 5 5
Fig. 5A None Rat-IgG Decreased Pax2 expression 6 0
B None Flk1 Ab Decreased Pax2 expression 6 5
C None Rat-IgG Decreased Osr1 expression 3 0
D None Flk1 Ab Decreased Osr1 expression 3 0
E None Rat-IgG Decreased Nanog expression 3 0
F None Flk1 Ab Decreased Nanog expression 3 3
G None Rat-IgG Decreased Wnt4 expression 3 0
H None Flk1 Ab Decreased Wnt4 expression 3 3
I None Rat-IgG Decreased Wt1 expression 3 0
J None Flk1 Ab Decreased Wt1 expression 3 0
Fig. 6A, part a Gfp None Increased Pax2 expression 8 0
A, part b Vegfa None Increased Pax2 expression 11 10
Fig. 6A, parts d,e Gfp vector Rat-IgG (as control) Decreased Pax2 expression 6 0
Fig. 6A, parts d,e Vegfa cDNA Rat-IgG (as control) Decreased Pax2 expression 6 0
Fig. 6A, parts d,e Gfp vector Flk1 Ab Decreased Pax2 expression 6 6
Fig. 6A, parts d,e Vegfa cDNA Flk1 Ab Decreased Pax2 expression 6 6
Not shown Gfp vector DMSO (as control) Decreased Pax2 expression 6 0
Not shown Vegfa cDNA DMSO (as control) Decreased Pax2 expression 6 0
Not shown Gfp vector SU1498 Decreased Pax2 expression 6 6
Not shown Vegfa cDNA SU1498 Decreased Pax2 expression 6 6
Fig. 6B Empty vector Rat-IgG (as control) Pax2 stimulation of Gdnf expression 3 0
Fig. 6B Pax2 cDNA Rat-IgG (as control) Pax2 stimulation of Gdnf expression 3 3
Fig. 6B Empty vector Flk1 Ab Pax2 stimulation of Gdnf expression 3 0
Fig. 6B Pax2 cDNA Flk1 Ab Pax2 stimulation of Gdnf expression 3 0
Fig. 6B Empty vector DMSO (as control) Pax2 stimulation of Gdnf expression 3 0
Fig. 6B Pax2 cDNA DMSO (as control) Pax2 stimulation of Gdnf expression 3 3
Fig. 6B Empty vector SU1498 Pax2 stimulation of Gdnf expression 3 0
Fig. 6B Pax2 cDNA SU1498 Pax2 stimulation of Gdnf expression 3 0
Fig. 6D, parts a-d Pax2 cDNA Rat-IgG Increased Pax2 mRNA expression 3 3
Fig. 6D, parts a-d Pax2 cDNA Flk1 Ab Increased Pax2 mRNA expression 3 0
Fig. 6D, parts a-d Pax2 cDNA DMSO Increased Pax2 mRNA expression 3 3
Fig. 6D, parts a-d Pax2 cDNA SU1498 Increased Pax2 mRNA expression 3 0
Fig. 6D, parts e-h Pax2 cDNA Rat-IgG Increased Pax2 protein expression 3 3
Fig. 6D, parts e-h Pax2 cDNA Flk1 Ab Increased Pax2 protein expression 3 0
Fig. 6D, parts e-h Pax2 cDNA DMSO Increased Pax2 protein expression 3 3
Fig. 6D, parts e-h Pax2 cDNA SU1498 Increased Pax2 protein expression 3 0
Fig. 6D, parts i,j Gfp vector Rat-IgG GFP fluorescence 3 3
Fig. 6D, parts i,j Gfp vector Flk1 Ab GFP fluorescence 3 3
Fig. 6D, parts i,j Gfp vector DMSO GFP fluorescence 3 3
Fig. 6D, parts i,j Gfp vector SU1498 GFP fluorescence 3 3
Fig. 7A None PBS/Flk1 Ab Increased branching and nephrons 4 0
Fig. 7A None Gdnf/Flk1Ab Increased branching and nephrons 4 4
Fig. 7B None PBS/Flk1 Ab Increased Pax2 mRNA expression 4 0
Fig. 7B None Gdnf/Flk1Ab Increased Pax2 mRNA expression 4 4
Fig. 7C None Rat-IgG(48/48) Decreased branching and nephrons 4 0
Fig. 7C None Flk1 Ab(48/48) Decreased branching and nephrons 4 0
The number of times each experiment was performed and the outcomes discussed in the text and shown in each figure.
*Data not shown in figures but referred to in the text.
†Dominant negative Flk1 cDNA referred to in the text.
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Stimulation of Vegfa expression in kidney organ
culture by injection of Wt1
Our previous work suggested that Wt1 may regulate the
expression of factors that regulate vascular development
(Natoli et al., 2002a). One such factor is Vegfa (Neufeld et al.,
1999). Wt1 and Vegfa are both highly expressed by podocytes
in the kidney glomerulus (Armstrong et al., 1993; Eremina and
Quaggin, 2004), leading us to hypothesize that Vegfa may be
a regulatory target of Wt1. Injection of a Wt1 expression
plasmid containing a Wt1 cDNA, without alternatively spliced
exon 5 or the KTS sequence present at the end of exon 9, led
to high-level expression of Vegfa at the site of injection [Fig.
2B, part a, compare with sense probe (part c) and with control
injection of a vector containing the Gfp cDNA (part b)].
Injection of a vector encoding Pax2 (Dressler et al., 1990) also
failed to induce expression of Vegfa (data not shown). Real
time-PCR for Vegfa also demonstrated increased expression of
Vegfa RNA at the Wt1 injection site (Fig. 2B, part d). Previous
studies have ascribed distinct functions to the different splice
forms of Wt1. However, the ability to induce Vegfa expression
was not restricted to a single splice form of Wt1. Rather, all
four major splice forms were able to induce expression of Vegfa
(Table 1, data not shown). This finding is, perhaps, not
surprising in view of recent results in which we had shown that
a targeted deletion of alternatively spliced exon 5 in mice had
no apparent phenotype (Natoli et al., 2002b), and Hammes et
al. (Hammes et al., 2001) had shown that embryos singly
expressing either the –KTS or +KTS versions of Wt1
experience normal early kidney development (see Discussion
for additional detail). Because we found no apparent difference
in the ability of Wt1 alternatively spliced isoforms to induce
expression of Vegfa, the remainder of the studies in this report
used the version of the Wt1 cDNA that did not include either
exon 5 or the KTS sequence.
Vegfa is expressed in the metanephric kidney
The expression pattern of Vegfa in the early kidney is shown
in Fig. 3A. Vegfa expression was present in the condensed
mesenchyme and highest in pretubular aggregates (Fig. 3A).
Lower levels of Vegfa were also present in the ureteric bud. In
older kidneys, expression was highest in podocytes of maturing
glomeruli. The mesenchymal expression of Vegfa overlapped
with that of Wt1, which was also in condensed mesenchyme
and in pretubular aggregates, and highest in podocytes of older
kidneys (data not shown) (see Armstrong et al., 1993; Eremina
et al., 2003).
Overexpression of Vegfa stimulates branching of the
ureteric bud
Vegf164 is a predominant isoform of Vegfa (Neufeld et al.,
1999). The findings of Tufro, that Vegfa could stimulate
branching morphogenesis and induction of nephrons were
confirmed both by adding Vegfa to the organ culture (Fig. 3B),
and by microinjection/electroporation of a Vegfa expression
vector (not shown). Addition of Vegfa neutralizing antibodies
to the organ culture also resulted in decreased branching and
nephron induction (Fig. 3C).
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Fig. 3. (A) Vegfa expression in early kidney development compared to Wt1. (a,b) E12.5 kidneys, fixed immediately after dissection and
sectioned. (c,d) E11.5 metanephric kidney rudiments placed in culture for 48 hours. (a,c) Vegfa antisense probe, (b) Wt1 antisense probe and (d)
Vegfa sense probe. Clear Vegfa expression is present in the condensed mesenchyme of the E12.5 kidney (a) overlapping significantly with Wt1
expression at the same timepoint (b). (B) Vegfa stimulation of branching and tubulogenesis. (a) Control PBS addition, (b) Vegfa addition,
Cytokeratin stain red, proximal tubule-binding lectin green. (c) Terminal branch tip (P<0.001) and (d) proximal tubule (P<0.001) quantitation
showing results of four pairs of organ cultures represented by (a) and (b), which are from the same embryo. (C) Antibody inhibition of
branching. (a) Control organ culture treated with rabbit IgG. (b) Organ culture from the same embryo as (a) treated with anti-Vegfa neutralizing
antibody. (c,d) Quantitation of four pairs of organ cultures treated as in (a) and (b); (c) terminal branch tips (P<0.001); (d) tubules as identified
by lectin staining for proximal tubules (P<0.001).
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Expression of the Vegfa receptor Flk1 in the early
kidney
Understanding the role of Vegfa in early kidney development
requires identification and localization of the Vegfa receptors
expressed at the initiation of kidney development. The two
major receptors for Vegfa are Flt1 (Vegfr1) and Flk1 (Vegfr2)
(Neufeld et al., 1999); Flk1 appears to be essential for
endothelial differentiation, whereas Flt1 appears to have a
more crucial role in vascular assembly (Fong et al., 1995; Fong
et al., 1999; Shalaby et al., 1997). Previous reports using Flk1-
lacZ knock-in mice and immunostaining for Flk1 have
identified a population of Flk1-expressing cells at the periphery
of the condensed mesenchyme and adjacent to the stalk of the
ureteric bud (Loughna et al., 1998; Robert et al., 1998; Tufro,
2000; Tufro et al., 1999; Tufro-McReddie et al., 1997).
Immunostaining of E13 kidneys and organ cultures with an
Flk1 antibody confirmed this expression pattern (Fig. 4A, part
a), and co-staining with anti-Pax2 (Fig. 4A, part b), a marker
of the condensed mesenchyme and the ureteric bud,
demonstrated their non-overlapping expression patterns (Fig.
4A, part c), thus demonstrating that the Flk1- and Pax2-
expressing cells represent distinct compartments in the early
kidney. Furthermore, staining for Pecam, a marker of mature
endothelial cells (Newman, 1997), identified a small subset of
the Flk1-positive cells (Fig. 4A, parts g,h,i), indicating that the
majority of Flk1-expressing cells in the early kidney are
angioblasts or immature endothelial cells.
Flk1 signaling is required to maintain differentiation
of the condensed mesenchyme
Next it was determined whether the stimulation of kidney
development by Vegfa required signaling through Flk1.
Signaling by Flk1 was blocked by three independent methods,
all of which yielded similar results. Addition of an Flk1-
blocking antibody (DC101 from ImClone Systems) (Fig. 4B),
addition of a chemical inhibitor of the kinase activity of Flk1
(tyrphostin SU1498) (data not shown) or microinjection and
electroporation of a dominant-negative truncation mutant form
of Flk1 (Tsou et al., 2002) (data not shown), all led to reduced
branching of the ureteric bud and reduced numbers of induced
nephrons (Fig. 4B).
To further examine the effect of angioblast-derived signals
on the differentiation of the mesenchymal component of the
early kidney, it was determined whether signaling through Flk1
is involved in maintaining expression of several genes
characteristically expressed by the condensed mesenchyme.
The expression of several known, and one novel, marker of the
condensed mesenchyme was examined by whole-mount in situ
hybridization in the presence or absence of the Flk1-blocking
antibody. Pax2 expression in the mesenchyme was decreased
in the presence of the Flk1-blocking antibody, as shown both
by in situ hybridization and real-time PCR, the latter indicating
an approximately fourfold decrease in expression level (Fig.
5A,B,K). Whether the expression of Pax2 in the ureteric bud
was affected is difficult to determine using whole-mount in situ
hybridization.
Pax2 has previously been shown to regulate the expression
of Gdnf (Brophy et al., 2001); and, as would be predicted in
the presence of decreased Pax2, Gdnf RNA levels measured by
real-time PCR were also decreased in the presence of the Flk1-
blocking antibody (Fig. 5L).
Osr1 (odd-skipped related 1) is a marker of the intermediate
mesoderm that continues to be expressed in the condensed
mesenchyme (So and Danielian, 1999). By contrast to those of
Pax2, Osr1 expression levels appeared unchanged in the
presence of the Flk1-blocking antibody (Fig. 5C,D), indicating
Fig. 4. (A) Antibody staining of Flk1, Pax2 and Pecam in E12.5
kidney frozen sections (a-c, g-i) and whole mounts of E11.5 kidney
organ cultures placed in culture for 48 hours (d-f, j-l). (a,d) Flk1;
(b,e) Pax2; (c,f) merge of preceding panels showing non-overlapping
expression of Flk1 and Pax2. (g,j) Flk1; (h,k) Pecam; (i,j) merge of
preceding two panels showing Pecam-expressing cells are a subset of
Flk1-expressing cells. (B) Flk1-blocking antibody effect on
branching and nephrogenesis. Cytokeratin green; proximal tubule
brush border antigen red. (a,b) From the same embryo. (a) Treatment
with rat IgG; (b) treatment with anti-Flk1; (c,d) quantitation of four
pairs of organ cultures represented by (a) and (b), (P<0.001 for both
terminal branch number and tubules).
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that Flk1 blockade did not non-specifically affect expression of
all genes in the organ culture.
Nanog, a homeobox-containing gene recently shown to be
required to preserve the multipotent state of embryonic stem
cells (Chambers et al., 2003; Mitsui et al., 2003) was also
identified as a novel marker of the condensed mesenchyme,
with an expression that decreased after treatment with Flk1-
blocking antibody (Fig. 5E,F), suggesting that it may be not a
marker of the most undifferentiated mesenchyme. Wnt4 is
a signaling molecule required for the mesenchymal-to-
epithelial transformation by which aggregates of condensed
mesenchyme begin to form tubules (Stark et al., 1994). As
would be predicted for a later marker involved in the
differentiation of nephrons, Wnt4 expression also decreased in
the presence of the Flk1-blocking antibody (Fig. 5G,H). By
contrast to Pax2 expression, which overlaps Wt1 in the
condensed mesenchyme, Wt1 expression itself did not decrease
in the presence of Flk1 blockade. However, instead of the usual
pattern of Wt1 expression, which is highest in the discrete
mesenchymal condensates around each derivative of the
ureteric bud (Fig. 5I) a more diffuse Wt1 expression pattern
was apparent (Fig. 5J), indicative of the decreased branching
and failure to form the usual discrete mesenchymal
condensates around each tip of the ureteric bud derivatives.
Similar results for each gene were obtained using SU1498, the
pharmacological inhibitor of signaling through Flk1 (data not
shown).
The Flk1-dependent signal acts on the condensed
mesenchyme
The reduced branching of the ureteric bud observed after
blockade of signaling though Flk1 could be due to a signal
from the angioblasts that acts directly on the ureteric bud, or
that acts on the mesenchyme, to indirectly affect branching.
To distinguish these possibilities, Vegfa was expressed by
microinjection/electroporation at the periphery of the
condensed mesenchyme. This resulted in a localized increase
in Pax2 expression adjacent to the injection site (Fig. 6A,
parts a,b), that was apparent within 6 hours of the injection,
and that could be inhibited by either the Flk1-blocking
antibody (Fig. 6A, parts d,e) or SU1498 (data not shown).
This observation is most consistent with the possibility that
the Flk1-dependent signal is acting directly on the
mesenchyme. By contrast, if the Flk1-dependent signal were
acting directly on the ureteric bud, it would be expected that
the ureteric bud would then induce higher levels of Pax2 in
its usual pattern within the condensed mesenchyme around
the ureteric bud.
The Flk1-dependent signal regulates stability of
Pax2 mRNA
As signaling through Flk1 is apparently required to maintain
high levels of Pax2 RNA in the condensed mesenchyme, it
can be hypothesized that reduced branching of the ureteric
bud upon blockade of Flk1 signaling would be due to
reduced expression of Pax2 and consequent decreased
stimulation of Gdnf expression. To further examine the role
of the Flk1-dependent signal, Gdnf expression in response to
Pax2 microinjection/electroporation in the condensed
mesenchyme was examined, in the presence or absence of
Flk1 blockade. Gdnf was abundantly expressed in response to
Pax2, but Flk1 blockade eliminated Gdnf induction by Pax2
(Fig. 6B).
To further examine the mechanism by which the Flk1-
dependent signal may regulate Pax2, the levels of Pax2 RNA
expression were measured in response to either a generalized
blockade of transcription by actinomycin-D (act-D) or a
specific blockade of Flk1 signaling by a pharmacological
agent, SU1498. As measured by real-time PCR, levels of Pax2
decreased 1000-fold over an 8-hour treatment period with act-
Development 132 (24) Research article
Fig. 5. Flk1 dependency of gene
expression. (A,C,E,G,I) treatment with Rat
IgG; (B,D,F,H,J) treatment with Flk1
blocking antibody. The probe used for in
situ hybridization is shown to the left of
each pair of panels. Each pair of panels is
representative of the number of
experiments noted in Table 1. Similar
results were obtained with SU1498, (not
shown). (K,L) Real-time PCR for Pax2 (K)
and Gdnf (L) demonstrated decreased Pax2
and Gdnf mRNA (P<0.001) after treatment
of organ cultures with the Flk1 blocking
antibody. All Pax2 and Gdnf Ct values
were normalized to Gapdh Ct values and
then converted to relative mRNA levels
using standard curves, as described in the
Materials and methods.
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D (Fig. 6C). By contrast, on treatment with
SU1498, Pax2 mRNA levels initially decreased
but reached a steady-state level significantly higher
than that resulting from treatment with act-D. No
additive effects were observed when act-D and
SU1498 were combined. At least three possible
explanations can be offered to account for these
observations: (1) the Flk1-dependent signal acts to
stabilize Pax2 RNA in the mesenchyme, and the
lower level observed after Flk1 blockade reflects a
high-turnover state of non-stabilized Pax2 RNA;
(2) the difference in Pax2 RNA levels between act-
D treatment and Flk1 blockade is due to retention
of ureteric bud expression of Pax2 in the latter
treatment, compared with complete loss of Pax2
RNA in the former treatment; (3) a third
possibility, that the angioblast signal stimulates
supra-basal transcription of Pax2, is also possible,
although the failure of ectopically expressed Pax2
to induce expression of Gdnf under conditions of
Flk1 blockade strongly suggests some degree of
post-transcriptional regulation.
Organ culture experiments do not allow the use of nuclear
run-on experiments to directly measure transcription rates.
However, the hypothesis that Flk1-dependent signals regulate
post-transcriptional regulation of Pax2 expression was tested
Fig. 6. (A) Flk1-dependent Vegfa induction of Pax2.
The injection is noted at the top of each panel, and the
antibody treatment and hybridization probes are noted
at the bottom of each panel. Gfp (a) or Vegfa (b-e)
expression vectors were injected at the edge of the
condensed mesenchyme. Rat IgG (d) or Flk1-blocking
antibody (e) were added at the time of injection. Six
hours after injection, cultures were analyzed by in situ
hybridization with Pax2 antisense (a,b,d,e) or sense (c)
probe. (B) Flk1-dependent Pax2 induction of Gdnf
expression. Panels are labeled as in A. Pax2 expression
(a,b.d,f) or control (c,d,g,h) vectors were injected and
Gdnf antisense probe was used in all panels. (C) Real-
time PCR analysis of Pax2 mRNA expression level in
organ cultures after Flk1 blockade or treatment with
actinomycin-D. Treatments are shown in the figure box.
SU1498, actinomycin-D, SU1498 with actinomycin-D
or DMSO, were added to the culture medium at the
beginning of the culture period, (time 0). At 0, 1.5, 3,
4.5, 6, or 7.5 hours after beginning cultures, real-time
PCR was performed to measure levels of Pax2 mRNA.
All Pax2 Ct values were normalized to the Gapdh Ct
values and converted to relative mRNA levels as
described in the methods. Relative RNA levels are
shown on a log scale. (D) Flk1 dependency of Pax2
expression. Panels a-h were injected with the Pax2
expression vector. The hybridization probes are noted at
the bottom of each panel (a-d), and the antibody
treatment is noted at the top (a-d) or bottom (e-h) of
each panel. (a,e) Rat IgG; (b,f) Flk1-blocking antibody;
(c,g) DMSO 1:1000; (d,h) SU1498 treatment. (a-d) In
situ hybridization with Pax2 antisense probe; (e-h)
staining with anti-Pax2 antibody. Pax2 mRNA or
protein expression in response to injection of the Pax2
expression vector could be blocked by antibody or
pharmacological inhibition of signaling through Flk1.
(i-l) Injections of the GFP expression vector, detecting
direct GFP fluorescence.
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further by examining Pax2 expression itself in response to
injection and electroporation of the Pax2 expression construct,
in the presence or absence of inhibitors of Flk1. It was observed
that when Flk1 inhibitors were present, much less Pax2 RNA
or protein could be detected in response to Pax2 injection
(compare Fig. 6D, parts a,c and b,d; and Fig. 6D, parts e,g and
f,h). By contrast, Flk1 blockade had no effect on expression of
a Gfp construct expressed from the same CMV promoter-
enhancer used to express Pax2 (Fig. 6D, parts i-l),
demonstrating that Flk1 blockade is not simply inhibiting
transcription from the CMV promoter used in the Pax2 (or Gfp)
expression vector(s). Thus, the results of this last experiment
are also consistent with post-transcriptional regulation of Pax2
by an Flk1-dependent signal.
The Flk1-dependent signal is dispensable
after initiation of kidney development
To further test the hypothesis that the Flk1-
dependent signal acts primarily on the
mesenchyme, Gdnf was added to the organ culture
medium in the presence of the Flk1 blockade. As
Gdnf acts directly on the ureteric bud, this should
be able to overcome any deficiency in the
condensed mesenchyme due to the absence of the
Flk1-dependent signal from the angioblasts.
Addition of Gdnf in the presence of the Flk1
blockade stimulated branching of the ureteric bud
(Fig. 7A). Surprisingly, addition of Gdnf also
rescued induction of nephrons (Fig. 7A); this was
not predicted because expression of Pax2 and Wnt4
were greatly decreased upon blockade of the Flk1-
dependent signal. However, it was also observed
that expression of Pax2 in the condensed
mesenchyme was also rescued by addition of Gdnf
(Fig. 7B). Together these results suggested that the
Flk1-dependent signal was required to initiate
kidney development, but that once Pax2 was able
to stimulate expression of Gdnf, and Gdnf was able
to elicit an inductive signal from the ureteric bud,
the Flk1-dependent signal might no longer be
required. As further support for this possibility, it
was observed that addition of the Flk1-blocking
antibody after organ cultures had already been
established for 48 hours, had little effect on the
extent of branching and nephron induction (Fig.
7C).
Discussion
Previous studies on the induction of the
metanephric kidney have considered the interaction
of two cell lineages, the metanephric mesenchyme
and the epithelial cells of the ureteric bud (Schedl
and Hastie, 2000). Our results provide support for
the requirement for a third cell type, the angioblast,
which appears to be involved in maintaining the
condensed mesenchyme in a differentiated state
capable of responding to the inductive influence of
the ureteric bud. We have shown that the Wt1 tumor
suppressor gene, previously shown to be required
for the initiation of kidney development, stimulates
the expression of Vegfa within the mesenchyme.
The target cells of Vegfa appear to be a population
of Flk1-expressing angioblasts found at the
periphery of the mesenchymal condensations.
There appears to be a reciprocal set of interactions
between the angioblasts and the mesenchyme that
are required to maintain the mesenchyme in
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Fig. 7. (A) Gdnf rescue of Flk1 blockade. (a) Flk1 block and (b) Flk1 block with
addition of Gdnf are stained for cytokeratin (red) and proximal tubule-binding
lectin (green). (a,b) From the same embryo. (c) Terminal branch number
(P<0.001) and (d) tubule number (P<0.001) quantification from four pairs of
cultures represented by (a) and (b). (B) Pax2 in situ hybridization of organ
cultures from E11.5 embryos cultured for 48 hours in the presence of (a) Flk1
block and (b) Flk1 block with addition of Gdnf. (C) Late addition of Flk1
blockade. (a,b) Organ cultures from the same embryo, obtained from E11.5
embryos, cultured for 48 hours before addition of Flk1-blocking antibody (b) or
control IgG (a), and cultured for an additional 48 hours. (c,d) Quantitation of
four pairs of organ cultures represented by (a) and (b). Differences are not
significant.
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differentiated state characterized by high expression of Pax2
and Gdnf. Vegfa appears to be the major component of the
mesenchyme-derived component of this reciprocal set of
inductive signals, and the angioblast signal remains to be
identified. However, once Gdnf expression has stimulated the
initial branching of the ureteric bud and the induction of
nephrons has begun, the Flk1-dependent signal appears not to
be required, and kidney development is maintained by the
interaction of the ureteric bud and the mesenchyme.
In embryos carrying a homozygous targeted mutation in the
Wt1 gene, the ureteric bud fails to grow out from the Wolffian
duct, and there is consequent apoptosis of the metanephric
mesenchyme (Kreidberg et al., 1993). It has been difficult to
identify potential targets of Wt1 for which a deficiency could
account for the renal agenesis phenotype, even though several
studies have identified potential Wt1 target genes in the gonad,
including Sry (Hammes et al., 2001; Hossain and Saunders,
2001) and Sf1 (Zfp162 – Mouse Genome Informatics)
(Wilhelm and Englert, 2002). Low levels of Gdnf were detected
in the metanephric mesenchyme of Wt1-deficient embryos
(Donovan et al., 1999), suggesting that Gdnf may not be a
target of Wt1, although it remains possible that Wt1 is involved
in boosting levels of Gdnf to achieve bud outgrowth. More
recently, siRNA to Wt1 was used in an organ culture system to
confirm the requirement for Wt1 in early kidney development,
but this approach was less amenable for identifying novel
target genes, because of the requirement for Wt1 to maintain
cell viability (Davies et al., 2004). The present study suggests
Vegfa as a novel candidate target gene for Wt1. The angioblast-
mesenchyme interaction mediated by Vegfa appears to be
crucial in maintaining the initial differentiated state of the
mesenchyme, and in the absence of this interaction, it is likely
that insufficient levels of Pax2 and Gdnf are present to elicit
outgrowth of the ureteric bud.
The conclusion that Flk1-expressing angioblasts express a
signal that is required to initiate kidney development depends
on their identification as the major, if not sole, cell type
expressing Flk1 in the early metanephric kidney.
Immunostaining for Flk1 and the use of Flk1-LacZ knock-in
mice has failed to detect expression in other cell types, and
particularly not in the ureteric bud. Furthermore, the
observations that (1) localized Vegfa injection/electroporation
results in adjacent Pax2 expression, as opposed to enhanced
Pax2 expression around the ureteric buds, and (2) addition of
Gdnf can overcome the Flk1 blockade, are both more
consistent with a model that invokes the requirement for
angioblasts, rather than direct stimulation of the ureteric bud
by Vegfa. However, the possibility that very low levels of Flk1,
not detectable by immunostaining or the use of knock-in mice,
are expressed by the ureteric bud and involved in Vegfa
stimulation of branching, remains a possibility that might be
examined by genetic ablation of the Flk1 gene in the ureteric
bud.
There are four major splice forms of the Wt1 gene, due to
alternative splicing of exon 5, and alternative insertion of a
three amino acid sequence, lysine-threonine-serine (KTS), at
the end of exon 9 (Haber et al., 1991). We recently showed that
elimination of exon 5 had no effect on kidney development and
function, and the role of this alternatively spliced exon remains
unknown (Natoli et al., 2002b). Hammes et al. (Hammes et al.,
2001) have published the results of gene targeting experiments
that allowed expression of either the +KTS or –KTS forms of
Wt1. In each case, homozygous mutant embryos showed
defective kidney development, with poorly developed
glomeruli, a phenotype more pronounced in the +KTS-only
kidneys. The difference in these phenotypes raised the question
of whether this indicated that the two splice forms of Wt1 have
entirely distinct functions, or whether the two phenotypes are
due to differences in severity, but due to the same function of
the different splice forms. Supporting the former possibility are
observations that the +KTS form of Wt1 associates with
spliceosomes (Larsson et al., 1995), and has a speckled nuclear
staining pattern, whereas the –KTS form has a more diffuse
staining pattern in the nucleus. In our microinjection and
electroporation system it has been observed that both the +KTS
and –KTS forms of Wt1 are capable of inducing expression of
Vegfa. However, this does not necessarily conflict with the
likely possibility that the +KTS and –KTS forms of Wt1 have
common functions early in kidney development but acquire
distinct functions during podocyte differentiation. Indeed, both
+KTS- and –KTS-only embryos apparently undergo normal
early kidney development (Hammes et al., 2001), implying that
they are interchangeable with regard to early functions of Wt1.
Previous studies examining liver and pancreas development
have identified roles for the vascular system, and in particular
Flk1-expressing cells in organogenesis (Lammert et al., 2001;
Matsumoto et al., 2001). Thus it appears to be an emerging
paradigm that organs require signals from angioblast-type
cells to stimulate or maintain organ-specific patterns of
differentiation. It is not known whether liver- and pancreas-
associated angioblastic cells are responding to Vegfa produced
by the mesenchymal components of these organs. It will also
be of great interest to eventually determine whether these
signal elaborated by pancreas-, liver- and kidney-associated
angioblasts are identical or differ between these organs.
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